Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Multiple Myeloma | 39 | 2024 | 5145 | 3.940 |
Why?
|
Monoclonal Gammopathy of Undetermined Significance | 5 | 2020 | 179 | 1.840 |
Why?
|
Bone Marrow | 9 | 2022 | 2911 | 1.190 |
Why?
|
Proteasome Endopeptidase Complex | 5 | 2022 | 1318 | 0.830 |
Why?
|
Immunoglobulin Light Chains | 4 | 2024 | 286 | 0.810 |
Why?
|
Aspartic Acid Proteases | 1 | 2022 | 9 | 0.800 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2022 | 21 | 0.800 |
Why?
|
Ethylene Glycols | 5 | 2024 | 196 | 0.770 |
Why?
|
Thrombotic Microangiopathies | 1 | 2023 | 123 | 0.760 |
Why?
|
Plasma Cells | 3 | 2020 | 597 | 0.680 |
Why?
|
Hypotension, Orthostatic | 1 | 2022 | 257 | 0.640 |
Why?
|
Paraproteinemias | 2 | 2019 | 250 | 0.620 |
Why?
|
Immunoproliferative Small Intestinal Disease | 1 | 2018 | 4 | 0.610 |
Why?
|
Aniline Compounds | 5 | 2024 | 1073 | 0.570 |
Why?
|
Amyloid | 3 | 2023 | 848 | 0.560 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5666 | 0.520 |
Why?
|
Tumor Microenvironment | 6 | 2022 | 3875 | 0.500 |
Why?
|
Receptors, Immunologic | 2 | 2021 | 1408 | 0.500 |
Why?
|
Histone Deacetylases | 1 | 2019 | 717 | 0.470 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 2014 | 83 | 0.460 |
Why?
|
Heavy Chain Disease | 1 | 2014 | 19 | 0.460 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2024 | 5301 | 0.410 |
Why?
|
Bone Marrow Transplantation | 1 | 2020 | 2692 | 0.400 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 479 | 0.380 |
Why?
|
Imidazoles | 2 | 2014 | 1172 | 0.380 |
Why?
|
Transplantation, Autologous | 3 | 2022 | 2112 | 0.370 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2022 | 11733 | 0.360 |
Why?
|
Thalidomide | 4 | 2024 | 885 | 0.350 |
Why?
|
Amyloidosis | 3 | 2023 | 865 | 0.340 |
Why?
|
Cysteine Proteinase Inhibitors | 2 | 2009 | 188 | 0.330 |
Why?
|
Quinolines | 1 | 2014 | 764 | 0.320 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1645 | 0.310 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4404 | 0.310 |
Why?
|
Cardiomyopathies | 5 | 2024 | 2021 | 0.300 |
Why?
|
Fluorine Radioisotopes | 2 | 2020 | 420 | 0.270 |
Why?
|
Indoles | 1 | 2014 | 1830 | 0.260 |
Why?
|
Mutation | 3 | 2024 | 30004 | 0.240 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2014 | 1405 | 0.230 |
Why?
|
Radiopharmaceuticals | 3 | 2024 | 2684 | 0.230 |
Why?
|
Humans | 56 | 2024 | 761222 | 0.230 |
Why?
|
Ikaros Transcription Factor | 1 | 2024 | 232 | 0.210 |
Why?
|
Complement Pathway, Alternative | 1 | 2023 | 113 | 0.210 |
Why?
|
Signal Transduction | 8 | 2021 | 23419 | 0.210 |
Why?
|
Immunoglobulin G | 1 | 2014 | 4537 | 0.200 |
Why?
|
Predictive Value of Tests | 5 | 2024 | 15308 | 0.190 |
Why?
|
Myeloma Proteins | 1 | 2021 | 71 | 0.190 |
Why?
|
Antibodies, Bispecific | 1 | 2023 | 196 | 0.180 |
Why?
|
Myocardium | 3 | 2024 | 4746 | 0.180 |
Why?
|
Neoplasms, Plasma Cell | 1 | 2021 | 39 | 0.180 |
Why?
|
Prognosis | 7 | 2024 | 29688 | 0.180 |
Why?
|
Bone Marrow Cells | 3 | 2021 | 2410 | 0.180 |
Why?
|
Plasmacytoma | 1 | 2021 | 171 | 0.180 |
Why?
|
Magnetic Resonance Imaging, Cine | 3 | 2024 | 1061 | 0.170 |
Why?
|
Apoptosis | 6 | 2023 | 9478 | 0.170 |
Why?
|
Dexamethasone | 5 | 2022 | 1945 | 0.160 |
Why?
|
Antineoplastic Agents | 6 | 2024 | 13632 | 0.160 |
Why?
|
14-3-3 Proteins | 1 | 2020 | 220 | 0.160 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2021 | 502 | 0.160 |
Why?
|
Microtubule-Associated Proteins | 1 | 2024 | 1075 | 0.160 |
Why?
|
Oligonucleotides, Antisense | 1 | 2021 | 457 | 0.160 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2024 | 1141 | 0.160 |
Why?
|
Natriuretic Peptide, Brain | 2 | 2024 | 1725 | 0.160 |
Why?
|
Endothelial Cells | 3 | 2021 | 3552 | 0.160 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2024 | 629 | 0.150 |
Why?
|
Campylobacter jejuni | 1 | 2018 | 24 | 0.150 |
Why?
|
Campylobacter Infections | 1 | 2018 | 31 | 0.150 |
Why?
|
Disease Progression | 4 | 2020 | 13511 | 0.150 |
Why?
|
Molecular Targeted Therapy | 4 | 2024 | 2813 | 0.150 |
Why?
|
Proton Pump Inhibitors | 1 | 2022 | 534 | 0.140 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2024 | 2897 | 0.140 |
Why?
|
Neoplasm, Residual | 1 | 2022 | 1008 | 0.140 |
Why?
|
Echocardiography, Doppler | 1 | 2020 | 898 | 0.130 |
Why?
|
Protein Biosynthesis | 2 | 2012 | 2091 | 0.120 |
Why?
|
Peptide Fragments | 2 | 2024 | 5103 | 0.120 |
Why?
|
Oligopeptides | 1 | 2020 | 1179 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9278 | 0.120 |
Why?
|
Ventricular Function, Left | 2 | 2024 | 3899 | 0.120 |
Why?
|
Boronic Acids | 3 | 2014 | 915 | 0.120 |
Why?
|
Exosomes | 1 | 2019 | 424 | 0.120 |
Why?
|
Immunologic Factors | 2 | 2014 | 1589 | 0.120 |
Why?
|
Diphosphonates | 2 | 2021 | 634 | 0.110 |
Why?
|
Osteogenesis | 1 | 2021 | 1273 | 0.110 |
Why?
|
Animals | 15 | 2024 | 168089 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1746 | 0.110 |
Why?
|
Mice | 11 | 2024 | 81330 | 0.110 |
Why?
|
Pyrazines | 3 | 2014 | 1202 | 0.100 |
Why?
|
Antihypertensive Agents | 1 | 2022 | 2019 | 0.100 |
Why?
|
Ubiquitin | 2 | 2008 | 839 | 0.100 |
Why?
|
Immunophenotyping | 2 | 2014 | 1867 | 0.090 |
Why?
|
Early Diagnosis | 2 | 2020 | 1186 | 0.090 |
Why?
|
Risk Factors | 5 | 2024 | 74241 | 0.090 |
Why?
|
Protein Folding | 1 | 2014 | 869 | 0.090 |
Why?
|
Cell Proliferation | 4 | 2023 | 10423 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2023 | 8531 | 0.090 |
Why?
|
Unfolded Protein Response | 1 | 2012 | 235 | 0.090 |
Why?
|
Back Pain | 1 | 2014 | 545 | 0.090 |
Why?
|
Aged | 12 | 2024 | 169292 | 0.080 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 6125 | 0.080 |
Why?
|
Minnesota | 1 | 2010 | 337 | 0.080 |
Why?
|
Precancerous Conditions | 1 | 2016 | 982 | 0.080 |
Why?
|
Middle Aged | 12 | 2024 | 220858 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2019 | 3210 | 0.080 |
Why?
|
Leupeptins | 1 | 2009 | 112 | 0.080 |
Why?
|
Bone Remodeling | 1 | 2012 | 583 | 0.080 |
Why?
|
Bone Neoplasms | 1 | 2021 | 2527 | 0.080 |
Why?
|
Translocation, Genetic | 1 | 2014 | 1391 | 0.080 |
Why?
|
Observation | 1 | 2010 | 310 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2020 | 3594 | 0.080 |
Why?
|
Azepines | 1 | 2010 | 328 | 0.070 |
Why?
|
Cell Line, Tumor | 6 | 2024 | 16954 | 0.070 |
Why?
|
Metabolomics | 1 | 2017 | 1658 | 0.070 |
Why?
|
Cell Differentiation | 3 | 2012 | 11512 | 0.070 |
Why?
|
Fatigue | 1 | 2014 | 1550 | 0.070 |
Why?
|
MicroRNAs | 1 | 2023 | 3758 | 0.070 |
Why?
|
Bone Density Conservation Agents | 1 | 2014 | 793 | 0.070 |
Why?
|
Biopsy | 2 | 2019 | 6781 | 0.070 |
Why?
|
Protease Inhibitors | 2 | 2009 | 752 | 0.070 |
Why?
|
Heart Failure | 3 | 2024 | 11701 | 0.060 |
Why?
|
Male | 13 | 2024 | 360703 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2024 | 58952 | 0.060 |
Why?
|
Mice, SCID | 3 | 2021 | 2621 | 0.060 |
Why?
|
HeLa Cells | 2 | 2009 | 3073 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2015 | 2820 | 0.060 |
Why?
|
Female | 13 | 2024 | 392552 | 0.060 |
Why?
|
Clinical Trials as Topic | 2 | 2024 | 8002 | 0.060 |
Why?
|
Phthalimides | 1 | 2024 | 34 | 0.060 |
Why?
|
Piperidones | 1 | 2024 | 37 | 0.060 |
Why?
|
Receptors, Interleukin-17 | 1 | 2024 | 82 | 0.060 |
Why?
|
Kidney | 1 | 2019 | 7033 | 0.060 |
Why?
|
Proteomics | 1 | 2017 | 3840 | 0.050 |
Why?
|
Calreticulin | 1 | 2024 | 113 | 0.050 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8519 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2009 | 3577 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1126 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13367 | 0.050 |
Why?
|
Amyloidogenic Proteins | 1 | 2023 | 154 | 0.050 |
Why?
|
Salvage Therapy | 2 | 2021 | 1264 | 0.050 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2047 | 0.050 |
Why?
|
Cell Communication | 1 | 2009 | 1651 | 0.050 |
Why?
|
Heart Ventricles | 2 | 2024 | 3813 | 0.050 |
Why?
|
TNF Receptor-Associated Factor 2 | 1 | 2021 | 56 | 0.050 |
Why?
|
Stress, Physiological | 1 | 2009 | 1405 | 0.050 |
Why?
|
Genomics | 1 | 2017 | 5829 | 0.050 |
Why?
|
Drug Administration Routes | 1 | 2021 | 150 | 0.050 |
Why?
|
Morpholines | 1 | 2024 | 581 | 0.050 |
Why?
|
Referral and Consultation | 1 | 2014 | 3608 | 0.050 |
Why?
|
Genetic Variation | 1 | 2016 | 6567 | 0.050 |
Why?
|
Prospective Studies | 5 | 2024 | 54437 | 0.040 |
Why?
|
Heart Transplantation | 2 | 2024 | 3258 | 0.040 |
Why?
|
Time Factors | 5 | 2024 | 39957 | 0.040 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11119 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2015 | 9187 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2018 | 7407 | 0.040 |
Why?
|
Nucleotidyltransferases | 1 | 2021 | 242 | 0.040 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2021 | 614 | 0.040 |
Why?
|
Retrospective Studies | 2 | 2022 | 80675 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 636 | 0.040 |
Why?
|
Dendritic Cells | 1 | 2009 | 2726 | 0.040 |
Why?
|
Parotid Gland | 1 | 2019 | 176 | 0.040 |
Why?
|
Pyrimidines | 1 | 2010 | 3027 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2024 | 64681 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2021 | 982 | 0.030 |
Why?
|
Autophagy | 1 | 2024 | 1327 | 0.030 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 731 | 0.030 |
Why?
|
Treatment Failure | 1 | 2022 | 2643 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2009 | 4744 | 0.030 |
Why?
|
Immunity | 1 | 2021 | 996 | 0.030 |
Why?
|
Tissue Distribution | 1 | 2019 | 2263 | 0.030 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2024 | 1892 | 0.030 |
Why?
|
Child | 1 | 2023 | 80154 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15841 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2010 | 5665 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2443 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2392 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2021 | 4851 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2010 | 7400 | 0.030 |
Why?
|
NF-kappa B | 1 | 2021 | 2475 | 0.030 |
Why?
|
Osteoclasts | 1 | 2016 | 711 | 0.030 |
Why?
|
Echocardiography | 1 | 2024 | 5006 | 0.020 |
Why?
|
Antigen-Presenting Cells | 1 | 2015 | 965 | 0.020 |
Why?
|
Transplantation, Heterologous | 2 | 2010 | 2381 | 0.020 |
Why?
|
Chromatin | 1 | 2023 | 2946 | 0.020 |
Why?
|
Osteoblasts | 1 | 2016 | 1144 | 0.020 |
Why?
|
Pilot Projects | 1 | 2023 | 8642 | 0.020 |
Why?
|
Contrast Media | 1 | 2021 | 5311 | 0.020 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2010 | 326 | 0.020 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2009 | 704 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2024 | 14610 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2012 | 2468 | 0.020 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2010 | 628 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2018 | 4739 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2015 | 3155 | 0.020 |
Why?
|
Chemotaxis | 1 | 2009 | 598 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22174 | 0.020 |
Why?
|
Immunoglobulin mu-Chains | 1 | 2006 | 62 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2010 | 0.020 |
Why?
|
Toll-Like Receptors | 1 | 2009 | 575 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2009 | 1334 | 0.020 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1168 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 210 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 2 | 2024 | 36415 | 0.020 |
Why?
|
Software | 1 | 2019 | 4431 | 0.020 |
Why?
|
bcl-2-Associated X Protein | 1 | 2006 | 282 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5032 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2021 | 7851 | 0.010 |
Why?
|
Doxorubicin | 1 | 2010 | 2224 | 0.010 |
Why?
|
Risk Assessment | 1 | 2024 | 24022 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8998 | 0.010 |
Why?
|
Cell Cycle | 1 | 2010 | 2926 | 0.010 |
Why?
|
Adult | 2 | 2021 | 221120 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2012 | 5871 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 3593 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9979 | 0.010 |
Why?
|
Immunoglobulin M | 1 | 2006 | 1527 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 2062 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12747 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2010 | 2803 | 0.010 |
Why?
|
Spleen | 1 | 2006 | 2290 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5778 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2006 | 2199 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39127 | 0.010 |
Why?
|
Cytokines | 1 | 2009 | 7386 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2006 | 9520 | 0.010 |
Why?
|
United States | 1 | 2020 | 72341 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2009 | 10203 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 2006 | 5783 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2006 | 9567 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2006 | 22128 | 0.000 |
Why?
|
Transcription Factors | 1 | 2006 | 12101 | 0.000 |
Why?
|